(Q38046079)

27 August 2017

title

Stereotactic body radiotherapy treatment of extracranial metastases (English)

1 reference

adaptive radiation therapy

27 August 2017

main subject

0 references

John P Kirkpatrick

2

0 references

author name string

Joseph K Salama

series ordinal

1

1 reference

27 August 2017

Fang-Fang Yin

series ordinal

3

1 reference

27 August 2017

language of work or name

English

0 references

publication date

25 September 2012

1 reference

Nature Reviews Clinical Oncology

27 August 2017

published in

1 reference

27 August 2017

volume

9

1 reference

27 August 2017

issue

11

1 reference

27 August 2017

page(s)

654-665

1 reference

Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis.

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

A rationale for the targeted treatment of oligometastases with radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Stereotactic body radiation therapy for inoperable early stage lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Phase I study of individualized stereotactic body radiotherapy of liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

The radiation oncologist's perspective on stereotactic radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Radiosurgery: where we were, are, and may be in the third millennium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Stereotactic body radiation therapy: the report of AAPM Task Group 101.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Stereotactic body radiation therapy: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Repositioning accuracy of a commercially available double-vacuum whole body immobilization system for stereotactic body radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

4-dimensional computed tomography imaging and treatment planning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Four-dimensional magnetic resonance imaging (4D-MRI) using image-based respiratory surrogate: a feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Image registration in intensity- modulated, image-guided and stereotactic body radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Impact of collimator leaf width and treatment technique on stereotactic radiosurgery and radiotherapy plans for intra- and extracranial lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Volumetric arc intensity-modulated therapy for spine body radiotherapy: comparison with static intensity-modulated treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

An experimental investigation on intra-fractional organ motion effects in lung IMRT treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Dosimetric comparison of treatment plans based on free breathing, maximum, and average intensity projection CTs for lung cancer SBRT

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Engaging the vascular component of the tumor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

An analysis of the dose-response for arteriovenous malformation radiosurgery and other factors affecting obliteration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Arteriovenous Malformation Radiosurgery Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Histopathology of arteriovenous malformations after gamma knife radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Stereotactic body radiotherapy for treatment of adrenal metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Stereotactic body radiation therapy for adrenal metastases: a retrospective review of a noninvasive therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Impact of target reproducibility on tumor dose in stereotactic radiotherapy of targets in the lung and liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Fluorodeoxyglucose positron emission tomography response and normal tissue regeneration after stereotactic body radiotherapy to liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Stereotactic body radiotherapy for lesions of the spine and paraspinal regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Stereotactic body radiosurgery for spinal metastases: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Stereotactic body radiotherapy is an effective treatment in reirradiating spinal metastases: current status and practical considerations for safe practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Phase II study on stereotactic body radiotherapy of colorectal metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

MicroRNA expression characterizes oligometastasis(es)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Stereotactic body radiation therapy for colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Stereotactic body radiation therapy using three fractions for isolated lung recurrence from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Oligometastases confined one organ from colorectal cancer treated by SBRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Phase II study of helical tomotherapy for oligometastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Outcome predictors of gamma knife radiosurgery for renal cell carcinoma metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Phase 1 study of stereotactic body radiotherapy and interleukin-2--tumor and immunological responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Immunologic correlates of the abscopal effect in a patient with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Induced sensitization of tumor stroma leads to eradication of established cancer by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

An overview of hypofractionation and introduction to this issue of seminars in radiation oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Radiation dose-volume effects in the stomach and small bowel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Radiation-associated liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Radiation dose-volume effects in the spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Spinal cord tolerance for stereotactic body radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Image-guided robotic radiosurgery for spinal metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

The Linear-Quadratic Model Is Inappropriate to Model High Dose per Fraction Effects in Radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Outcomes after Resection of Synchronous or Metachronous Hepatic and Pulmonary Colorectal Metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Advances in radiotherapy and implications for the next century: a historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Oligometastases revisited

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Liver resection for colorectal metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Stereotactic High Dose Fraction Radiation Therapy of Extracranial Tumors Using An Accelerator: Clinical experience of the first thirty-one patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Stereotactic body radiation for the spine: a review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

A comparison of two immobilization systems for stereotactic body radiation therapy of lung tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Quantification and minimization of uncertainties of internal target volume for stereotactic body radiation therapy of lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Dosimetric study using different leaf-width MLCs for treatment planning of dynamic conformal arcs and intensity-modulated radiosurgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Dose fractionation, dose rate and iso-effect relationships for normal tissue responses.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

The Effect of Multiple Small Doses of X Rays on Skin Reactions in the Mouse and a Basic Interpretation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Tumor response to radiotherapy regulated by endothelial cell apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Radiation-induced changes of brain tissue after radiosurgery in patients with arteriovenous malformations: dose/volume-response relations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Stereotactic Body Radiation Therapy (SBRT) for lung metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Central thoracic lesions treated with hypofractionated stereotactic body radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Stereotactic radiotherapy of primary liver cancer and hepatic metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Radiation therapy for liver metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Partial volume tolerance of the spinal cord and complications of single-dose radiosurgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Multifractionated image-guided and stereotactic intensity-modulated radiotherapy of paraspinal tumors: A preliminary report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Analysis of patients with oligometastases undergoing two or more curative-intent stereotactic radiotherapy courses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Radiosurgery for the treatment of spinal melanoma metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Stereotactic radiosurgery for spinal metastases from renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Adjuvant irradiation for cervical lymph node metastases from melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Dose-response in stereotactic irradiation of lung tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.166

Feasibility and toxicity of hypofractionated image guided radiation therapy for large volume limited metastatic disease.

31 March 2020

1 reference

12 December 2020

Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450).

1 reference

12 December 2020

Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment

1 reference

12 December 2020

Target localization using scanner-acquired SPECT data

1 reference

12 December 2020

The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT).

1 reference

12 December 2020

10.1038/NRCLINONC.2012.166

Identifiers

DOI

1 reference

27 August 2017

1 reference